“Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis”, Arch Ital Urol Androl, vol. 87, no. 2, pp. 121–129, Jul. 2015, doi: 10.4081/aiua.2015.2.121.